June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
BridgeBio Pharma (BBIO) stock forecast for 2026
Updated: June 2, 2025 (08:42)
Sector: HealthcareThe share price of BridgeBio Pharma, Inc. (BBIO) now
50/200 Day Moving Average: $34.54 / $30.09
This figure corresponds to the Average Price over the previous 50/200 days. For BridgeBio Pharma stocks, the 50-day moving average is the resistance level today.
For BridgeBio Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in BridgeBio Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BridgeBio Pharma stock price in 2026. How much will one BridgeBio Pharma share be worth in 2026? Is it worth taking profit / loss on BBIO stock now or waiting? What are analysts' forecasts for BridgeBio Pharma stock?
We forecast BridgeBio Pharma stock performance using neural networks based on historical data on BBIO stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
BridgeBio Pharma, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for BridgeBio Pharma analysts is $58.78. Today 200 Day Moving Average is the support level (30.09 $). 50 Day Moving Average is the support level (34.54 $).
Historical and forecast chart of BridgeBio Pharma, Inc. stock
The chart below shows the historical price of BridgeBio Pharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BBIO stock price can be found in the table below.
BridgeBio Pharma, Inc. is engaged in the discovery, development and supply of various drugs for genetic diseases. The company has a portfolio of 20 development programs that include candidate products from early discovery to late development.
BridgeBio Pharma (BBIO) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 32.57 | 31.43 | 34.10 | 7.83 % |
| Feb | 34.16 | 33.17 | 35.05 | 5.36 % |
| Mar | 33.41 | 30.94 | 35.21 | 12.14 % |
| Apr | 31.77 | 29.33 | 32.63 | 10.13 % |
| May | 31.71 | 30.82 | 33.90 | 9.07 % |
| Jun | 31.61 | 29.97 | 32.82 | 8.67 % |
| Jul | 33.07 | 31.18 | 34.66 | 10.02 % |
| Aug | 35.94 | 34.58 | 38.50 | 10.18 % |
| Sep | 38.07 | 36.81 | 41.11 | 10.46 % |
| Oct | 41.64 | 39.02 | 42.60 | 8.41 % |
| Nov | 44.52 | 41.13 | 46.03 | 10.64 % |
| Dec | 43.32 | 41.67 | 44.48 | 6.33 % |
BridgeBio Pharma information and performance
421 KIPLING STREET, PALO ALTO, CA, US
Market capitalization of the BridgeBio Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of BBIO shares in the company outstanding by the market price of one share.
EBITDA of BridgeBio Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
BridgeBio Pharma price target for 2026 by month
Target values for the price of one BridgeBio Pharma share for Jan 2026.
In Jan, the Positive dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 7.832% volatility is expected.
Pessimistic target level: 31.43
Optimistic target level: 34.10
Target values for the price of one BridgeBio Pharma share for Feb 2026.
In Feb, the Positive dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 5.360% volatility is expected.
Pessimistic target level: 33.17
Optimistic target level: 35.05
Target values for the price of one BridgeBio Pharma share for Mar 2026.
In Mar, the Negative dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 12.144% volatility is expected.
Pessimistic target level: 30.94
Optimistic target level: 35.21
Target values for the price of one BridgeBio Pharma share for Apr 2026.
In Apr, the Negative dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 10.127% volatility is expected.
Pessimistic target level: 29.33
Optimistic target level: 32.63
Target values for the price of one BridgeBio Pharma share for May 2026.
In May, the Negative dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 9.074% volatility is expected.
Pessimistic target level: 30.82
Optimistic target level: 33.90
Target values for the price of one BridgeBio Pharma share for Jun 2026.
In Jun, the Negative dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 8.671% volatility is expected.
Pessimistic target level: 29.97
Optimistic target level: 32.82
Target values for the price of one BridgeBio Pharma share for Jul 2026.
In Jul, the Positive dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 10.019% volatility is expected.
Pessimistic target level: 31.18
Optimistic target level: 34.66
Target values for the price of one BridgeBio Pharma share for Aug 2026.
In Aug, the Positive dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 10.177% volatility is expected.
Pessimistic target level: 34.58
Optimistic target level: 38.50
Target values for the price of one BridgeBio Pharma share for Sep 2026.
In Sep, the Positive dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 10.463% volatility is expected.
Pessimistic target level: 36.81
Optimistic target level: 41.11
Target values for the price of one BridgeBio Pharma share for Oct 2026.
In Oct, the Positive dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 8.407% volatility is expected.
Pessimistic target level: 39.02
Optimistic target level: 42.60
Target values for the price of one BridgeBio Pharma share for Nov 2026.
In Nov, the Positive dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 10.638% volatility is expected.
Pessimistic target level: 41.13
Optimistic target level: 46.03
Target values for the price of one BridgeBio Pharma share for Dec 2026.
In Dec, the Negative dynamics for BridgeBio Pharma, Inc. shares will prevail with possible monthly volatility of 6.329% volatility is expected.
Pessimistic target level: 41.67
Optimistic target level: 44.48
Related stocks from Healthcare sector
